HCPLive

Cannabis Damages Young Brains More than Previously Thought

New findings from a team of Canadian researchers led by Dr. Gabriella Gobbi, researcher, neuroscience axis, Research Institute of the McGill University Health Centre, and psychiatrist and associate professor, Department of Psychiatry, McGill University, show that young brains are affected more by the illicit drug than originally thought. In fact, the researchers found that long-term daily consumption of cannabis among teens can induce anxiety- and depression-like behaviors in adulthood, as well as other irreversible, long-term effects on the brain.
 
Although previous epidemiological studies have demonstrated the affect on behavior of cannabis use among teenagers, Dr. Gobbi explained that the current study “is one of the first to focus on the neurobiological mechanisms at the root of this influence of cannabis on depression and anxiety in adolescents.” The study also looked at whether the brains of teenagers are more susceptible than those of adults to the neurological effects of cannabis use. Indeed, the study is the first to show that more serious damage is caused with cannabis consumption during adolescence than during adulthood.
 
“Teenagers who are exposed to cannabis have decreased serotonin transmission, which leads to mood disorders, as well as increased norepinephrine transmission, which leads to greater long-term susceptibility to stress,” Dr. Gobbi stated.
 
More on the Effects of Cannabis: Resources for You and Your Patients
 
 
 
 
 

Most Popular

Recommended Reading

Making the transition from transfemoral to transradial access may provide longterm benefits for acute coronary syndrome patients, but changing years of training to the newer method also figures to be a longterm project for the cardiac community.
For patients with acute coronary syndrome there has been one longstanding treatment method which doctors have used for many years. In recent years interventional cardiologists have been looking at whether a fresh approach might be best for this patient group.
What is currently considered to be the “gold standard” for post-shoulder surgery pain management may not be as effective as what once was believed.
Neuroinflammatory and ischemic diseases including Alzheimer's disease, Parkinson's disease, and stroke are notoriously difficult to treat. Researchers have looked for ways to quantify, understand and reduce cerebral inflammation, and to date have been able to determine that microglia-driven inflammation destroys neuronal populations.
$vAR$